Project Antibody Technology definition

Project Antibody Technology means (a) the Project Antibody Inventions; (b) the Project Antibody Patents, (c) the Sequence Information and Results; and (d) all Intellectual Property Rights therein.
Project Antibody Technology means (a) the Project Antibody Inventions, (b) the Project Antibody Patents, (c) the Sequence Information and Results, and (d) all Intellectual Property Rights therein that are Controlled by Paragon and its Affiliates. For clarity, if the Parties execute a License Agreement with respect to a particular Research Program and the Research Term for such Research Program continues following execution of such License Agreement, any Project Antibody Technology first conceived, reduced to practice or otherwise generated following the execution of the License Agreement shall be licensed to Oruka under such License Agreement.
Project Antibody Technology means all data, results and other Technology that is generated by Integral in the execution of the Project whether or not delivered to Context, excluding any portion of the Integral CLDN6 Antibody IP and Integral Platform IP disclosed therein.

Examples of Project Antibody Technology in a sentence

  • Subject to the rights and licenses granted to Oruka in this Agreement, as between the Parties, Paragon or its Affiliates shall own all right, title and interest in and to all Project Antibody Technology, irrespective of inventorship.

  • Subject to the terms and conditions of this Agreement, on a Research Program-by-Research Program basis, and effective only during the Term, Paragon hereby grants to Oruka a limited, exclusive, royalty-free license, without the right to sublicense, under the Project Antibody Technology arising from such Research Program solely to evaluate the Option and for the purpose of allowing Xxxxx to determine whether to exercise the Option with respect to such Research Program.

  • Oruka and its Affiliates shall cause all of its and their employees who, in each case, generated, conceived of or created any Project Antibody Technology to assign without additional consideration all ownership rights in such Project Antibody Technology to Paragon.

  • Oruka and its Affiliates shall cause all of its and their employees who, in each case, generated, conceived of or created any Project Antibody Technology or Selected IL-23 Project Antibody Technology to assign without additional consideration all ownership rights in such Project Antibody Technology and Selected IL-23 Project Antibody Technology to Paragon.

  • Oruka shall execute and deliver, and shall cause its Affiliates to execute and deliver, such additional documents, instruments, conveyances and assurances and take any such further actions as may be reasonably required to ensure that all right, title and interest in the Project Antibody Technology is effectively assigned to and held by Paragon.

  • Subject to the terms and conditions of this Agreement, on a Research Program-by-Research Program basis, Paragon hereby grants to Oruka, during the Term and subject to delivery of the Election Notice in accordance with Section ‎4.3, an exclusive option (“Option”) to be granted an exclusive license under the Project Antibody Technology for the applicable Research Program to Develop, Manufacture and Commercialize Project Antibodies, Derived Antibodies and Products in the Field in the Territory.

  • Xxxxx agrees to assign and hereby assigns to Paragon all of Xxxxx’s right, title and interest in and to the Project Antibody Technology, including any and all Intellectual Property Rights therein.

  • Xxxxx agrees to assign and hereby assigns to Paragon all of Xxxxx’s right, title and interest in and to the Project Antibody Technology and the Selected IL-23 Project Antibody Technology, including any and all Intellectual Property Rights therein.

  • Oruka shall execute and deliver, and shall cause its Affiliates to execute and deliver, such additional documents, instruments, conveyances and assurances and take any such further actions as may be reasonably required to ensure that all right, title and interest in the Project Antibody Technology and the Selected IL-23 Project Antibody Technology is effectively assigned to and held by Paragon.

Related to Project Antibody Technology

  • Licensed Technology means the Licensed Know-How and Licensed Patents.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • Licensed Know-How means all Know-How that (a) is Controlled by Pfizer or any of its Affiliates as of the effective date of the Pfizer-MPP Agreement, (b) directly relates to the use of the Compound, Product or Licensed Product in the Field, and (c) is not in the public domain or otherwise generally known. For the avoidance of doubt, (i) Licensed Know-How shall not include any Know-How to the extent solely and directly related to any other Pfizer compound or to the extent related to the use of the Compound, Product or Licensed Product outside the Field and (ii) Licensed Know-How includes only that Know-How, designated by Pfizer in its sole discretion, necessary for the manufacture, registration and commercialization of the Compound and/or Licensed Product for use in the Field. For the avoidance of doubt, Licensed Know-How excludes any Know-How related to ritonavir that has been (either as of the Effective Date or at any time during the term of this Agreement) in-licensed by Pfizer from any Third Party.